Manuscripts

Search by keyword, year, or author name.

Showing 1591 manuscripts.

In utero nucleoside reverse transcriptase inhibitor exposure and cancer in HIV-uninfected children: an update from the pediatric AIDS clinical trials group 219 and 219C cohorts.

Susan Brogly, Ph.D., Paige L. Williams, Ph.D., George Seage, III, Sc.D., M.P.H., Lynne M. Mofenson, M.D., F.A.A.P., Russell B. Van Dyke, M.D., James M. Oleske, M.D. In utero nucleoside reverse transcriptase inhibitor exposure and cancer in HIV-uninfected children: an update from the pediatric AIDS clinical trials group 219 and 219C cohorts. Journal of Acquired Immune Deficiency Syndromes. 2006 Apr 01; 41(4):535-536.

Year

2006

Journal

Journal of Acquired Immune Deficiency Syndromes

Impact of MCP-1-2518-G allele on the HIV-1 disease of children in the U.S.

Kumud K. Singh, Michael Hughes, Ph.D., Jie (Ellen) Chen, M.S., Stephen A. Spector, M.D. Impact of MCP-1-2518-G allele on the HIV-1 disease of children in the U.S. AIDS. 2006 Mar 14; 20(3):475-478.

Year

2006

Journal

AIDS

Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection.

Paige L. Williams, Ph.D., Deborah S. Storm, R.N.,Ph.D, Grace Montepiedra, Ph.D., Sharon L. Nichols, Ph.D., Betsy Kammerer, Ph.D., Patricia Sirois, Ph.D., John J. Farley, M.D., M.P.H., Kathleen Malee, Ph.D. Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection. Pediatrics. 2006 Dec 01; 118(6):e1745 - e1757. PMID: 17101712.

Year

2006

Journal

Pediatrics

Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy.

Mark J. Abzug, M.D., Stephen Ira Pelton, M.D., Lin-Ye Song, Ph.D., Terence Fenton, Ed.D., Myron Levin, M.D., Sharon Appelbaum Nachman, M.D., William Borkowsky, M.D., Howard Max Rosenblatt, M.D., John F. Marcinak, M.D., Arry Dieudonne, M.D., Elaine J. Abrams, M.D., Indu Pathak. Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy. Pediatric Infectious Disease Journal. 2006 Oct 01; 25(10):920 - 929. PMID: 17006288.

Year

2006

Journal

Pediatric Infectious Disease Journal

Study

P1024

Effects of HCV treatment on cytokine expression during HCV/HIV coinfection

Jason T. Blackard, Ph.D., Minhee Kang, M.S., Ph.D., Kenneth E. Sherman, M.D., Ph.D., Margaret James Koziel, M.D. Effects of HCV treatment on cytokine expression during HCV/HIV coinfection. Journal of Interferon and Cytokine Research. 2006 Nov 01; 26(11):834-8.

Year

2006

Journal

Journal of Interferon and Cytokine Research

Low CD4+ T cell nadir is an independent predictor of lower HIV-specific immune responses in chronically HIV-1-infected subjects receiving highly active antiretroviral therapy

M. Atif Siddique, Kelly E. Hartman, B.A., M.A.T., Elvira Dragileva, Marla Silman, M.S., Tebeb Gebretsadik, Ayumi Shintani, Laurence Peiperl, M.D., Fred T. Valentine, M.D., Spyros A. Kalams, M.D. Low CD4+ T cell nadir is an independent predictor of lower HIV-specific immune responses in chronically HIV-1-infected subjects receiving highly active antiretroviral therapy. Journal of Infectious Diseases. 2006 Sep 01; 194(5):661-5.

Year

2006

Journal

Journal of Infectious Diseases

Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency

Elias (Lou) K. Halvas, Ph.D., Grace M. Aldrovandi, MD, Peter Balfe, Ph.D., Ingrid A. Beck, M.S., Valerie F. Boltz, John Coffin, M.D., Lisa M. Frenkel, M.D., J. Darren Hazelwood, B.A., Victoria A. Johnson, M.D., Mary Kearney, Andrea Kovacs, M.D., Daniel R. Kuritzkes, M.D., Karin J. Metzner, Dwight V. Nissley, Marek J Nowicki, Ph.D., Sarah Palmer, Ph.D., Ranier Ziermann, Richard Y. Zhao, Cheryl L. Jennings, B.S., James W. Bremer, Ph.D., Donald J. Brambilla, Ph.D., John W. Mellors, M.D. Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency. Journal of Clinical Microbiology. 2006 Jul 01; 44(7):2612-4.

Year

2006

Journal

Journal of Clinical Microbiology

A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleukin-2 cycles to promote efficient control of viral replication (ACTG A5024).

J. Michael Kilby, M.D., R. Pat Bucy, M.D., Ph.D., Donna Mildvan, M.D., Margaret A. Fischl, M.D., Jorge L. Santana, M.D., Jeffrey L. Lennox, M.D., Christopher D. Pilcher, M.D., Andrew R. Zolopa, M.D., Jody Lawrence, M.D., Richard B. Pollard, M.D., Rafaelle El-Habib, Ph.D., David Sahner, M.D., Lawrence Fox, M.D., Ph.D., Evgenia Aga, M.Sc., Ronald J. Bosch, Ph.D., Ronald T. Mitsuyasu, M.D. A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleukin-2 cycles to promote efficient control of viral replication (ACTG A5024). Journal of Infectious Diseases. 2006 Dec 15; 194(12):1672-6. PMID: 17109338.

Year

2006

Journal

Journal of Infectious Diseases